1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow ID110521156: new trials by email Literature Review of ID110521156 trials Research Report on ID110521156
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects ID110521156, Placebo of 110521156 - Healthy Adult Subjects | Phase 1 | Recruiting | IlDong Pharmaceutical Co Ltd | 36 | 2024-11-13 | 2024-12-24 |
| Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects ID110521156, Placebo of ID110521156 - Healthy Adult Subjects | Phase 1 | Completed | IlDong Pharmaceutical Co Ltd | 36 | 2023-11-20 | 2024-11-25 |
IlDong Pharmaceutical Co Ltd (2)
South Korea (2)